Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

New Antiretrovirals, New Formulations, and New Strategies for HIV Treatment

New Antiretrovirals, New Formulations, and New Strategies for HIV Treatment

, by Liz Highleyman

For people with HIV, new treatment options offer flexibility and better safety profiles. Find out what’s coming down the drug pipeline. Read More

RAPID Program Leads to Faster HIV Suppression

RAPID Program Leads to Faster HIV Suppression

, by Liz Highleyman

A new study of San Francisco’s RAPID program verifies that starting treatment on the same day as an HIV diagnosis helps more people achieve viral suppression in fewer days. Read More

START Trial Shows Benefits of Early Treatment, Supports ART For All

START Trial Shows Benefits of Early Treatment, Supports ART For All

, by Liz Highleyman

Complete results from the START trial leave no room for doubt about benefits of early HIV treatment—and will influence development of world’s ART guidelines. Read More

Early Antiretroviral Therapy: Progress in HIV Cure Research

Early Antiretroviral Therapy: Progress in HIV Cure Research

, by Liz Highleyman

Early delivery of antiretroviral therapy (ART) soon after HIV infection holds promise as a way to reduce the size of the viral reservoir. What does this mean for HIV cure research? Read More

Predicting HIV Rebound: Progress in HIV Cure Research

Predicting HIV Rebound: Progress in HIV Cure Research

, by Liz Highleyman

When HIV treatment is stopped, viral load rebounds. New research that can predict viral load rebound might prove useful for researchers working on an HIV cure. Read More